1-8 of 8
Russell G. Jones
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6046: Enhanced Acod1 expression in cancer cells promotes immune evasion

James H. Schofield, Joseph Longo, Sean Murphy, Ryan Sheldon, Mark A. Hawk, Emma Albano, Russell G. Jones, Xin Lu, Zachary T. Schafer
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6046.
https://doi.org/10.1158/1538-7445.AM2023-6046
Published: 04 April 2023
View article titled, Abstract 6046: Enhanced <em>Acod1</em> expression in cancer cells promotes immune evasion
Journal Articles

Abstract 1381: Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cells

Jianping He, Abigail M. Abikoye, Brett P. McLaughlin, Ryan S. Middleton, Ryan Sheldon, Russell G. Jones, Zachary T. Schafer
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1381.
https://doi.org/10.1158/1538-7445.AM2023-1381
Published: 04 April 2023
View article titled, Abstract 1381: Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cells
Journal Articles

Abstract 2331: Metabolic evasion of mCRPC immunotherapy by ACOD1 production of itaconate

James H. Schofield, Mark A. Hawk, Sharif Rahmy, Ryan D. Sheldon, Casey Leimbach, Seunghoon Sun, Xin Lu, Russell G. Jones, Zachary T. Schafer
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2331.
https://doi.org/10.1158/1538-7445.AM2021-2331
Published: 01 July 2021
View article titled, Abstract 2331: Metabolic evasion of mCRPC immunotherapy by ACOD1 production of itaconate
Journal Articles

Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy

Samuel D. Saibil, Michael St. Paul, Robert C. Laister, Carlos R. Garcia-Batres, Kavita Israni-Winger, Alisha R. Elford, Natasha Grimshaw, Céline Robert-Tissot, Dominic G. Roy, Russell G. Jones, Linh T. Nguyen, Pamela S. Ohashi
Journal: Cancer Research
Cancer Res (2019) 79 (3): 445–451.
https://doi.org/10.1158/0008-5472.CAN-17-3053
Published: 01 February 2019
View article titled, Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy
Open the PDF for Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy in another window
Includes: Supplementary data
Journal Articles

Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis

Camille Lehuédé, Fanny Dupuy, Rebecca Rabinovitch, Russell G. Jones, Peter M. Siegel
Journal: Cancer Research
Cancer Res (2016) 76 (18): 5201–5208.
https://doi.org/10.1158/0008-5472.CAN-16-0266
Published: 15 September 2016
View article titled, Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis
Open the PDF for Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis in another window
Journal Articles

Abstract 3367: Understanding the role of metabolic reprogramming in breast cancer progression and metastasis

Fanny Dupuy, Julianna Blagih, Sébastien Tabariès, Julie St-Pierre, Russell G. Jones, Peter M. Siegel
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3367.
https://doi.org/10.1158/1538-7445.AM2014-3367
Published: 01 October 2014
View article titled, Abstract 3367: Understanding the role of metabolic reprogramming in breast cancer progression and metastasis
Journal Articles

Abstract 491: Selective killing of oncogenically transformed cells by arsenic trioxide and trolox

Genevieve G. J. Redstone, Jessica N. Nichol, Brandon Faubert, Russell G. Jones, Koren K. Mann, Wilson H. Miller
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 491.
https://doi.org/10.1158/1538-7445.AM2014-491
Published: 01 October 2014
View article titled, Abstract 491: Selective killing of oncogenically transformed cells by arsenic trioxide and trolox
Journal Articles

Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth

Monica Buzzai, Russell G. Jones, Ravi K. Amaravadi, Julian J. Lum, Ralph J. DeBerardinis, Fangping Zhao, Benoit Viollet, Craig B. Thompson
Journal: Cancer Research
Cancer Res (2007) 67 (14): 6745–6752.
https://doi.org/10.1158/0008-5472.CAN-06-4447
Published: 17 July 2007
View article titled, Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth
Open the PDF for Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth in another window
Includes: Supplementary data